Cargando…
Antiviral potential of 3′-sialyllactose- and 6′-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses
Current treatment options for influenza virus infections in humans are limited and therefore the development of novel antivirals is of high priority. Inhibiting influenza virus attachment to host cells would provide an early and efficient block of the infection and thus, receptor analogs have been c...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972948/ https://www.ncbi.nlm.nih.gov/pubmed/31964943 http://dx.doi.org/10.1038/s41598-020-57608-4 |
_version_ | 1783489943616618496 |
---|---|
author | Günther, Sira Carolin Maier, Julian David Vetter, Janine Podvalnyy, Nikita Khanzhin, Nikolay Hennet, Thierry Stertz, Silke |
author_facet | Günther, Sira Carolin Maier, Julian David Vetter, Janine Podvalnyy, Nikita Khanzhin, Nikolay Hennet, Thierry Stertz, Silke |
author_sort | Günther, Sira Carolin |
collection | PubMed |
description | Current treatment options for influenza virus infections in humans are limited and therefore the development of novel antivirals is of high priority. Inhibiting influenza virus attachment to host cells would provide an early and efficient block of the infection and thus, receptor analogs have been considered as options for antiviral treatment. Here, we describe the rapid and efficient synthesis of PAMAM dendrimers conjugated with either 3′-sialyllactose (3SL) or 6′-sialyllactose (6SL) and their potential to inhibit a diverse range of human and avian influenza virus strains. We show in a hemagglutination inhibition (HAI) assay that human IAV strains can be inhibited by (6SL)- and to a lesser extent also by (3SL)-conjugated PAMAM dendrimers. In contrast, avian strains could only be inhibited by (3SL)-conjugated dendrimers. Importantly, the differential sensitivities of human and avian IAV to the two types of sialyllactose-conjugated dendrimers could be confirmed in cell-based neutralization assays. Based on our findings, we suggest to further develop both, (3SL)- and (6SL)-conjugated PAMAM dendrimers, as influenza virus inhibitors. |
format | Online Article Text |
id | pubmed-6972948 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-69729482020-01-27 Antiviral potential of 3′-sialyllactose- and 6′-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses Günther, Sira Carolin Maier, Julian David Vetter, Janine Podvalnyy, Nikita Khanzhin, Nikolay Hennet, Thierry Stertz, Silke Sci Rep Article Current treatment options for influenza virus infections in humans are limited and therefore the development of novel antivirals is of high priority. Inhibiting influenza virus attachment to host cells would provide an early and efficient block of the infection and thus, receptor analogs have been considered as options for antiviral treatment. Here, we describe the rapid and efficient synthesis of PAMAM dendrimers conjugated with either 3′-sialyllactose (3SL) or 6′-sialyllactose (6SL) and their potential to inhibit a diverse range of human and avian influenza virus strains. We show in a hemagglutination inhibition (HAI) assay that human IAV strains can be inhibited by (6SL)- and to a lesser extent also by (3SL)-conjugated PAMAM dendrimers. In contrast, avian strains could only be inhibited by (3SL)-conjugated dendrimers. Importantly, the differential sensitivities of human and avian IAV to the two types of sialyllactose-conjugated dendrimers could be confirmed in cell-based neutralization assays. Based on our findings, we suggest to further develop both, (3SL)- and (6SL)-conjugated PAMAM dendrimers, as influenza virus inhibitors. Nature Publishing Group UK 2020-01-21 /pmc/articles/PMC6972948/ /pubmed/31964943 http://dx.doi.org/10.1038/s41598-020-57608-4 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Günther, Sira Carolin Maier, Julian David Vetter, Janine Podvalnyy, Nikita Khanzhin, Nikolay Hennet, Thierry Stertz, Silke Antiviral potential of 3′-sialyllactose- and 6′-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses |
title | Antiviral potential of 3′-sialyllactose- and 6′-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses |
title_full | Antiviral potential of 3′-sialyllactose- and 6′-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses |
title_fullStr | Antiviral potential of 3′-sialyllactose- and 6′-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses |
title_full_unstemmed | Antiviral potential of 3′-sialyllactose- and 6′-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses |
title_short | Antiviral potential of 3′-sialyllactose- and 6′-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses |
title_sort | antiviral potential of 3′-sialyllactose- and 6′-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972948/ https://www.ncbi.nlm.nih.gov/pubmed/31964943 http://dx.doi.org/10.1038/s41598-020-57608-4 |
work_keys_str_mv | AT gunthersiracarolin antiviralpotentialof3sialyllactoseand6sialyllactoseconjugateddendriticpolymersagainsthumanandavianinfluenzaviruses AT maierjuliandavid antiviralpotentialof3sialyllactoseand6sialyllactoseconjugateddendriticpolymersagainsthumanandavianinfluenzaviruses AT vetterjanine antiviralpotentialof3sialyllactoseand6sialyllactoseconjugateddendriticpolymersagainsthumanandavianinfluenzaviruses AT podvalnyynikita antiviralpotentialof3sialyllactoseand6sialyllactoseconjugateddendriticpolymersagainsthumanandavianinfluenzaviruses AT khanzhinnikolay antiviralpotentialof3sialyllactoseand6sialyllactoseconjugateddendriticpolymersagainsthumanandavianinfluenzaviruses AT hennetthierry antiviralpotentialof3sialyllactoseand6sialyllactoseconjugateddendriticpolymersagainsthumanandavianinfluenzaviruses AT stertzsilke antiviralpotentialof3sialyllactoseand6sialyllactoseconjugateddendriticpolymersagainsthumanandavianinfluenzaviruses |